Markets:

Overview

News

Currencies

International

Treasuries

Royal Bank of Canada (TSX:RY)

235.09 +0.06 (+0.03%)

Streaming Delayed Price Updated: 10:31 AM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

31 32 Next >

Tesla Bull Unfazed By Stock Slump On Elon Musk's 'Decades Perspective,' Says This Factor Will Be Next Major Boost ↗

March 15, 2024

"Elon doesn't think about things on a day-to-day or month-to-month basis; He's looking at things from a years, if not decades, perspective," said RBC Capital Markets analyst Tom Narayan.

Via Benzinga

What's In Store For Nike In Q3 Earnings? Analyst Sees Revenue Decline In North America & EMEA ↗

March 12, 2024

RBC Capital Markets analyst maintains Outperform rating on Nike but lowers price forecast to $110 ahead of its Q3 fiscal 2024 earnings release, despite highlighting China momentum and marketing...

Via Benzinga

RBC Capital Maintains Outperform Rating for Lexeo Therapeutics: Here's What You Need To Know ↗

March 12, 2024

Via Benzinga

RBC Just Cut Its Price Target on Lucid Motors (LCID) Stock in Half ↗

March 08, 2024

LCID stock has fallen by about 25% year-to-date to the $3 level. RBC analyst Tom Narayan believes that's where it should trade.

Via InvestorPlace

This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO ↗

March 08, 2024

REGENXBIO's promising gene therapy advancements! RBC Capital Markets upgraded REGENXBIO (RGNX), citing impressive RGX-202 trial results in Duchenne patients.

Via Benzinga

Why This Analyst Halves Lucid Group's Price Forecast Despite 12%-23% Higher Tech Efficiency Than Tesla ↗

March 08, 2024

Despite citing Lucid's superior tech efficiency over Tesla, RBC analyst Tom Narayan halves price forecast to $3 from $6, citing concerns over licensing discussions and sedan demand woes.

Via Benzinga

Carvana Stock Drives Higher On Analyst Upgrade ↗

March 08, 2024

RBC Capital analyst Brad Erickson said the bear case for the stock has become "increasingly unprovable," and Carvava's recent rally has the potential to continue even higher. The analyst sees any...

Via Benzinga

Here's How Much $100 Invested In RBC Bearings 15 Years Ago Would Be Worth Today ↗

March 08, 2024

Via Benzinga

RBC Capital Maintains Sector Perform Rating for Dana: Here's What You Need To Know ↗

March 08, 2024

Via Benzinga

RBC Just Doubled Its Price Target on Carvana (CVNA) Stock ↗

March 08, 2024

Carvana stock is climbing higher on Friday after shares of CVNA got a new price target and rating from RBC Capital analysts.

Via InvestorPlace

ChargePoint's Shifting Fortunes: Analyst Lowers Forecast Citing Slow EV Market And Emerging Cost Reduction Strategies ↗

March 06, 2024

ChargePoint Holdings, Inc. (NYSE: CHPT) is downgraded by RBC Capital Markets amid concerns over sluggish EV sales and poor customer sentiment.

Via Benzinga

What's Going On With GitLab Stock Tuesday? ↗

March 05, 2024

RBC analyst reiterates GitLab as Outperform with $80 price target. Q4 revenue beat estimates but stock fell on mixed 2025 guidance. Upside potential from new products & growth drivers.

Via Benzinga

Tesla Investors Need To 'Understand What The Stock Is Ultimately,' Says RBC Analyst: 'It's Not A Car Company' ↗

March 05, 2024

Tom Narayan, an analyst at RBC Capital Markets, has a unique perspective on Tesla. He believes that the company's core business is not just about cars, but also about autonomy and energy storage.

Via Benzinga

Newly Listed American Healthcare REIT: Stock Trades At Discount, But Analysts Favor Its Risk-Reward Balance ↗

March 04, 2024

American Healthcare REIT (AHR) post-IPO success, with Truist's Buy rating projecting 32% return, and RBC's Outperform rating highlighting strong earnings growth. JMP sees potential multiple expansion,...

Via Benzinga

Lyft And DoorDash Stocks Are Trading Higher Monday - Here's Why ↗

March 04, 2024

RBC Capital analyst upgraded Lyft & DoorDash stocks, raising price targets. Improved execution, partnerships & growth potential driving confidence.

Via Benzinga

Lyft And DoorDash Rise On Upgrades. Analyst Says They Should Partner Up. ↗

March 04, 2024

Lyft stock and DoorDash gained Monday on an upgrade from RBC Capital. Analysts said the two companies could benefit by teaming up.

Via Investor's Business Daily

RBC Capital Maintains Sector Perform Rating for GMS: Here's What You Need To Know ↗

March 01, 2024

Via Benzinga

RBC Capital Maintains Outperform Rating for Gaming and Leisure Props: Here's What You Need To Know ↗

February 29, 2024

Via Benzinga

Shift4 Payments: Analysts Highlight Growth Opportunities Despite Q4 Challenges ↗

February 28, 2024

RBC Capital analyst maintained Shift4 Payments with Outperform rating and raised price target from $80 to $94. Q1 revenue projected at $279.6M.

Via Benzinga

Warrior Met Coal's Ballooning Development Costs Prompt Analysts To Rethink Projections ↗

February 23, 2024

RBC analysts lower price target for Warrior Met Coal to $64 due to higher costs at Blue Creek mine. Capex expected to be $1B in 2024.

Via Benzinga

What's Going On With Booking Holdings Stock After Earnings? ↗

February 23, 2024

RBC Capital analyst Brad Erickson maintained Booking Holdings with an Outperform and raised the price target from $3550 to $3900, and Wedbush analyst Scott Devitt reiterated Booking Holdings with an...

Via Benzinga

RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know ↗

February 23, 2024

Via Benzinga

Navigating Discover's Merger With Capital One: Analyst Highlights Opportunities And Challenges Ahead ↗

February 22, 2024

RBC Capital Markets downgrades Discover Financial to Sector Perform with increased price target of $140. Merger with Capital One expected to be accretive and generate $2.7B in synergies. Analyst sees...

Via Benzinga

Here's How Much You Would Have Made Owning RBC Bearings Stock In The Last 15 Years ↗

February 21, 2024

Via Benzinga

This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space ↗

February 16, 2024

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset...

Via Benzinga

RBC Capital Maintains Sector Perform Rating for NMI Holdings: Here's What You Need To Know ↗

February 15, 2024

Via Benzinga

RBC Illuminates Solar Sector, Launches Coverage For 4 Solar Equipment Leaders ↗

February 14, 2024

RBC Capital Markets highlighted favorable public policy and declining costs within the solar industry and initiated coverage on several solar equipment suppliers, including First Solar, Enphase Energy,...

Via Benzinga

Topics Supply Chain

RBC Capital Maintains Outperform Rating for Datadog: Here's What You Need To Know ↗

February 14, 2024

Via Benzinga

Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month ↗

February 09, 2024

"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins...

Via Benzinga

RBC Capital's Rating Upgrade Propels IGM Biosciences Into Immunology Limelight ↗

February 09, 2024

IGM Biosciences' strategic shift to immunology with promising bispecific drug, imvotamab. RBC Capital upgraded stock to Outperform, anticipating $21 price target. Data expected in 2H 2024 validates its...

Via Benzinga

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.